
A practical AI + human QC model to turn KOL engagement into timely CRM follow-up.
Thursday, April 16th, 2026
10 AM (EDT) | 4 PM (CEST)
CEO
CEO
The countdown has started
Oncology teams are under pressure to move faster, prove impact, and personalize HCP engagement at scale. The problem is rarely a lack of tools. Most teams already invest in powerful platforms, yet only use a fraction of what they pay for. The rest of the intelligence stays trapped in disconnected systems, slides, and email threads that never reach the field when it matters most.
On April 16th, Pierre Metrailler will sit down with Sherry Crowe, CEO of OncoConnect and 30-year veteran of oncology commercial strategy, to unpack what “good” actually looks like when you try to use AI for oncology engagement.
Sherry shares why AI outputs often look convincing but fail under scrutiny, and why the missing ingredient is a practical human quality layer that validates KOL accuracy, catches inaccuracies before they reach customers, and turns raw data into a trusted direction the field can act on.
Together, they make the case for a more effective model: use-case-driven intelligence that can be requested on demand, validated quickly, and pushed into the CRM so field teams can act while the moment still matters.
The discussion connects how real HCP interactions at congresses, in webinars, and during advisory boards generate the first-party behavioral signals that make AI genuinely useful, and how syncing those signals directly into your CRM in real time enables timely follow-up and measurable commercial outcomes.
Onomi is the event-powered omnichannel solution that helps life science companies to create personalized, engaging, and compliant experiences for Healthcare Professionals. From omnichannel webinars and advisory boards to in-person congresses and standalone meetings, Onomi covers a wide range of medical event use cases, while enabling successful omnichannel strategies through deep CRM integrations including Veeva CRM, Veeva Vault CRM, IQVIA OCE, and Salesforce.
With 22+ years of unrivaled experience in the event technology industry, Onomi is the first choice for HCP engagement. Onomi technology is trusted by 15 of the top 20 life science companies.
For more information about how Onomi can help you increase HCP engagement and gather valuable data to drive effective follow-up, reach out today.
CEO
OncoConnect
Sherry Crowe is CEO of OncoConnect, an oncology-focused advisory firm helping biotech and pharma companies accelerate go-to-market success. With more than 30 years in the oncology ecosystem, she brings deep expertise in KOL engagement, market access, medical affairs, and launch strategy. She has built trusted relationships across oncologists, investigators, fellows, oncology pharmacy leaders, and key industry networks nationwide.
Through OncoConnect, Sherry combines innovation with experience, including a partnership with an AI platform that delivers rapid, use-case-driven intelligence. Her team applies a human quality-control layer to ensure insights are accurate, actionable, and commercially relevant. She is known for helping teams define their strategy, identify the right stakeholders, and execute high-impact advisory boards and engagement programs with precision and speed.
CEO
Pierre is an event technology pioneer with over 20 years of experience. After joining SpotMe in 2001, he expanded the company’s vision from hardware-based networking devices to comprehensive event engagement solutions. He led the company’s transformation to a SaaS platform in 2011, with a strong focus on enterprise customers. As CEO since 2016, Pierre has pursued a CRM-first strategy and addressed critical industries’ unmet needs, launching Onomi, an event-powered omnichannel solution for life sciences. He holds degrees from the Swiss Federal Institute of Technology, Lausanne and INSEAD.